Subscribe to continue reading
Subscribe to get access to the rest of this post and other subscriber-only content.
Sanofi to acquire British pharmaceutical company Vicebio for $ 1.6 billion
Sanofi plans to acquire British biotech Vicebio for up to $1.6 billion, enhancing its respiratory vaccine portfolio with innovative technology and access to next-generation vaccine candidates.
Eurasia Business News 